⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY
globenewswire.com
SPRY
ARS Pharmaceuticals, Inc. (SPRY) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 5, 2026 Deadline
accessnewswire.com
SPRY
ARS PHARMACEUTICALS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY
globenewswire.com
SPRY
Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
SPRY
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Pentair plc (PNR), Datavault AI Inc. (DVLT), and ARS Pharmaceuticals, Inc. (SPRY) Announced by Holzer & Holzer, LLC
globenewswire.com
PNR
DVLT
SPRY
Securities Lawsuit Alert: ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
Portnoy Law Firm Announces Class Action on Behalf of ARS Pharmaceuticals, Inc. Investors
globenewswire.com
SPRY
SPRY Shareholder Alert: ARS Pharmaceuticals Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt
globenewswire.com
SPRY
Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. (SPRY) Shareholders of Class Action Lawsuit and October 5, 2026 Deadline
accessnewswire.com
SPRY